Health
Bezlotoxumab reduces odds of recurrent C. difficile infection in transplant recipients – Healio
Bezlotoxumab significantly reduced the incidence of recurrent Clostridioides difficile infection among solid-organ transplant…
Bezlotoxumab significantly reduced the incidence of recurrent Clostridioides difficile infection among solid-organ transplant and hematopoietic-cell transplant recipients, according to a study published in Open Forum Infectious Diseases.
“Solid-organ and…
Continue Reading
-
General22 hours agoMitch Marsh inspires Australia to three-wicket win over New Zealand in third T20I
-
General21 hours agoNothing to see here *wink wink*
-
General20 hours agoNewcastle Jets defeat semi-professional Heidelberg United 3-1 to lift first Australia Cup
-
General23 hours agoThis isn’t progress, it’s punishment